CA1275044A - Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same - Google Patents

Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same

Info

Publication number
CA1275044A
CA1275044A CA000473706A CA473706A CA1275044A CA 1275044 A CA1275044 A CA 1275044A CA 000473706 A CA000473706 A CA 000473706A CA 473706 A CA473706 A CA 473706A CA 1275044 A CA1275044 A CA 1275044A
Authority
CA
Canada
Prior art keywords
antibody
antigen
bovid
fowl
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000473706A
Other languages
English (en)
French (fr)
Inventor
Lee R. Beck
Ralph J. Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Application granted granted Critical
Publication of CA1275044A publication Critical patent/CA1275044A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1275—Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA000473706A 1984-02-07 1985-02-06 Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same Expired - Lifetime CA1275044A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57780484A 1984-02-07 1984-02-07
US577,804 1984-02-07
US622,130 1984-06-19
US06/622,130 US4748018A (en) 1984-02-07 1984-06-19 Method of passive immunization of mammals using avian antibody

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CA000581406A Division CA1276883C (en) 1984-02-07 1988-10-26 Protein antibody composition derived from bovid milk and from avian egg
CA000581407A Division CA1276884C (en) 1984-02-07 1988-10-26 Protein antibody derived from serum of a bovid

Publications (1)

Publication Number Publication Date
CA1275044A true CA1275044A (en) 1990-10-09

Family

ID=27077340

Family Applications (3)

Application Number Title Priority Date Filing Date
CA000473706A Expired - Lifetime CA1275044A (en) 1984-02-07 1985-02-06 Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same
CA000581406A Expired - Lifetime CA1276883C (en) 1984-02-07 1988-10-26 Protein antibody composition derived from bovid milk and from avian egg
CA000581407A Expired - Lifetime CA1276884C (en) 1984-02-07 1988-10-26 Protein antibody derived from serum of a bovid

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA000581406A Expired - Lifetime CA1276883C (en) 1984-02-07 1988-10-26 Protein antibody composition derived from bovid milk and from avian egg
CA000581407A Expired - Lifetime CA1276884C (en) 1984-02-07 1988-10-26 Protein antibody derived from serum of a bovid

Country Status (12)

Country Link
US (1) US4748018A (enExample)
EP (2) EP0395120B1 (enExample)
JP (6) JP2548115B2 (enExample)
AT (1) ATE135016T1 (enExample)
CA (3) CA1275044A (enExample)
DE (1) DE3504221C2 (enExample)
DK (2) DK166905B1 (enExample)
GR (1) GR850323B (enExample)
HK (1) HK1000183A1 (enExample)
IE (1) IE64365B1 (enExample)
IL (1) IL74155A (enExample)
NZ (1) NZ211030A (enExample)

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US5853765A (en) * 1982-06-03 1998-12-29 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
EP0225254B1 (en) * 1985-11-25 1994-03-16 Ghen Corporation Specific antibody-containing substance from eggs and method of production and use thereof
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5565550A (en) * 1987-05-04 1996-10-15 Dana Farber Cancer Institute Antibodies to ICAM-2, and fragments thereof
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
JP2641228B2 (ja) * 1988-01-22 1997-08-13 鐘紡株式会社 抗体およびそれを有効成分とするう蝕予防剤、並びにこれらの製造方法
US5059419A (en) * 1988-06-09 1991-10-22 Grand Laboratories, Inc. Streptococcus suis antiserum and its use in treating Streptococcus suis infections
JP2689511B2 (ja) * 1988-08-18 1997-12-10 ライオン株式会社 食 品
US6511664B1 (en) 1989-03-09 2003-01-28 Dana Farber Cancer Institute Intercellular adhesion molecule—2 and its binding ligands
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US6932968B1 (en) 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
US7005560B1 (en) * 1989-10-27 2006-02-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5958413A (en) * 1990-11-01 1999-09-28 Celltech Limited Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
JP2553445B2 (ja) * 1992-12-17 1996-11-13 同仁医薬化工株式会社 抗体の安定化方法
FI955692A7 (fi) * 1993-05-26 1996-01-24 Stolle Res & Development Anti-kolesteroleminen muna, rokote ja valmistusmenetelmä sekä käyttö
US6068862A (en) * 1993-06-30 2000-05-30 Taiyo Kagaku Co., Ltd. Tea-derived feed additive and animal feed containing the same
WO1995019570A1 (en) * 1994-01-14 1995-07-20 Genentech, Inc. Antagonists to insulin receptor tyrosine kinase inhibitor
ES2279511T3 (es) * 1994-02-09 2007-08-16 Epitopix Llc Inmunizacion activa utilizando una proteina receptor de sideroforo.
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5814316A (en) * 1994-08-05 1998-09-29 Wisconsin Alumni Research Foundation Compound to mimick a naturally occurring peptide's effect
CA2196594A1 (en) * 1994-08-05 1996-02-22 Mark E. Cook Use of antibodies to cck to improve feed efficiency
US5939269A (en) * 1994-12-28 1999-08-17 The Regents Of The University Of California Antagonists to insulin receptor tyrosine kinase inhibitor
CA2218601A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Treatment for verotoxin-producing escherichia coli
FI955389A0 (fi) * 1995-11-09 1995-11-09 Antti Sakari Aaltonen Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
ATE266676T1 (de) * 1996-03-12 2004-05-15 Ovogenix Immunpharma Gmbh Verwendung von aviären, vitellinen, gegen hiv- antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
WO1998014209A1 (en) * 1996-10-02 1998-04-09 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease
JP3430853B2 (ja) * 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
WO1998055143A1 (en) * 1997-06-04 1998-12-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
US6086878A (en) * 1997-08-21 2000-07-11 Dcv, Inc. Method of increasing muscle protein and reducing fat in animals
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů
US6395273B1 (en) * 1998-06-10 2002-05-28 Promega Corporation Prevention and treatment of inflammatory bowel disease
JP2000351735A (ja) * 1999-04-09 2000-12-19 Akzo Nobel Nv カンピロバクターワクチン
US7241443B1 (en) * 1999-07-15 2007-07-10 Camas Incorporated Immunogen adherence inhibitor and method of making and using same
US7238351B2 (en) * 1999-07-15 2007-07-03 Peter Nash Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
WO2001013928A1 (fr) * 1999-08-24 2001-03-01 Ortho Corporation Co., Ltd. Procedes de pasteurisation d'une substance immune contenant un facteur anti-inflammatoire et son utilisation
US6706267B1 (en) * 1999-09-14 2004-03-16 Arkion Life Sciences Llc Glucosamine and egg for reducing inflammation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
AU2001249388A1 (en) 2000-03-24 2001-10-08 Trouw Nutrition Usa Combination of plasma and hyperimmunized products for increased performance
DK1353689T3 (da) * 2001-01-03 2006-07-31 Epitopix Llc Immuniseringspræparater og anvendelse deraf
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
AU2002318137A1 (en) * 2001-05-18 2002-12-03 Arkion Life Sciences Method of increasing uniformity in avians
CA2392344A1 (en) * 2001-07-02 2003-01-02 Nutratech Inc. Method for removal of pathogens from a localized environment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
WO2003061693A1 (en) * 2001-12-28 2003-07-31 Camas, Incorporated Immunogen adherence and method of making and using same
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
EP1487465A4 (en) * 2002-02-11 2007-05-30 Arkion Life Sciences Llc CLEANED CYTOKIN-INHIBITING FACTOR
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
US6729265B2 (en) * 2002-06-27 2004-05-04 Arkion Life Sciences Llc Supplemented antibody feed to enter the circulating system of newborns
US9701737B2 (en) * 2003-02-19 2017-07-11 Camas, Incorporated Immunogen adherence and method of making and using same
ES2371395T3 (es) * 2003-02-19 2011-12-30 Camas Incorporated Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo.
BR0318333A (pt) * 2003-07-07 2006-07-11 Luiz Fernando Mesquita processo de obtenção de complexo liofilizado a partir de segregado extraìdo da glándula de mamìferos, seu uso no tratamento de imunodeficiências e método de tratamento
US8329192B2 (en) 2003-09-19 2012-12-11 Epitopix Llc Campylobacter polypeptides and methods of use
CA2561800C (en) * 2004-04-16 2011-10-18 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
US8877187B2 (en) * 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070065452A1 (en) * 2005-07-25 2007-03-22 Avianax Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
US20070264264A1 (en) * 2005-08-30 2007-11-15 La Belle Associates, Inc. Method and composition for conferring immunity in mammals
CA2521156A1 (en) * 2005-09-16 2007-03-16 John Hare Antibodies as growth promoting agents
EP1790358A1 (en) * 2005-11-23 2007-05-30 Université de Reims Champagne-Ardennes Protein constructs designed for targeting and lysis of cells
AU2007281934B2 (en) 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
JP4753808B2 (ja) * 2006-06-20 2011-08-24 アサマ化成株式会社 感染症予防食品添加用組成物
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
US8282928B2 (en) * 2007-05-30 2012-10-09 The Governors Of The University Of Alberta Anti-gluten egg yolk antibodies for the treatment of celiac disease
ES2635870T3 (es) 2007-07-09 2017-10-05 Nestec S.A. Métodos para reducir las alergias provocadas por alérgenos ambientales
KR20100072228A (ko) 2007-08-31 2010-06-30 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
MX2011002309A (es) * 2008-09-02 2011-09-29 Huan Nguyen Anticuerpos de aves especificos para virus de influenza y metodos tecnologicamente sencillos de su fabricacion y uso.
US20110262477A1 (en) 2008-10-06 2011-10-27 University Of Chicago Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
HRP20160274T1 (hr) 2009-04-03 2016-04-08 University Of Chicago Pripravci i metode vezane za varijante proteina a (spa)
MX2011011376A (es) 2009-04-27 2012-04-20 Immuron Ltd Preparacion de inmunoglobulina enriquecida con anti-lps, para utilizarse en tratamiento y/o profilaxis de un trastorno patologico.
US10266585B2 (en) 2009-08-28 2019-04-23 The Board Of Regents Of The Univerity Of Texas System Methods of treating brain injury
EP2555794A4 (en) 2010-04-05 2014-01-15 Univ Chicago COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
WO2011140550A2 (en) * 2010-05-07 2011-11-10 Camas Incorporated Immunogen adherence and method of making and using same
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
CA2808361A1 (en) 2010-08-17 2012-02-23 Immuron Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of inflammatory bowel disease
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CA2818827C (en) * 2010-11-23 2024-02-13 Pantheryx, Inc. Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US9556281B2 (en) 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
AU2013252888B2 (en) 2012-04-26 2018-06-14 University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
WO2013162746A1 (en) 2012-04-26 2013-10-31 University Of Chicago Staphylococcal coagulase antigens and methods of their use
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
EP2986316B1 (en) 2013-04-19 2023-01-25 Immuron Limited Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use
WO2019183500A1 (en) 2018-03-23 2019-09-26 Hung Chiung Yu Coccidioides antigens and methods of their use
US11339387B2 (en) 2018-05-22 2022-05-24 The Government Of The United States Of America As Represented By The Secretary Of Homeland Security Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
WO2020051408A1 (en) 2018-09-07 2020-03-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions and methods for preventing and/or treating filarial disease
WO2020176637A1 (en) 2019-02-26 2020-09-03 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
CA3139981A1 (en) 2019-05-14 2020-11-19 The University Of Chicago Methods and compositions comprising staphylococcus protein a (spa) variants
US11701423B2 (en) 2021-03-12 2023-07-18 Lay Sciences, Inc. Hyperimmunized egg product for treatment or prevention of coronavirus infection
AU2022258701A1 (en) 2021-04-16 2023-10-26 Prodigy Biotech Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft-versus-host disease
WO2022243769A1 (en) 2021-05-17 2022-11-24 Societe Des Produits Nestle Sa Cat food supplements comprising an anti-fel-d1 molecule and an animal digest
WO2023212604A1 (en) 2022-04-27 2023-11-02 Lay Sciences, Inc. Targeted anti-sglt1 avian igy antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
AU2023269062A1 (en) 2022-05-13 2024-11-21 Prodigy Biotech, Inc. Formulations for oral delivery of polypeptides, antibodies and proteins and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US3646193A (en) * 1969-07-25 1972-02-29 Joseph B Michaelson Iga antibody from lacteal fluids
CH590064A5 (enExample) * 1973-11-28 1977-07-29 Biokema Sa
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
US4585651A (en) * 1978-10-17 1986-04-29 Stolle Research & Development Corporation Active/passive immunization of the internal female reproductive organs
GB2057451B (en) * 1979-09-05 1983-05-05 South African Inventions Immunological preparations comprising egg yolk antibodies
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
NZ201698A (en) * 1981-08-31 1985-12-13 S L Gaffin Composition of antibodies specific to endotoxins
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit

Also Published As

Publication number Publication date
JPS60248628A (ja) 1985-12-09
CA1276883C (en) 1990-11-27
DE3504221C2 (de) 1994-05-19
IL74155A (en) 1989-06-30
JP2548115B2 (ja) 1996-10-30
JPH08231427A (ja) 1996-09-10
AU583808B2 (en) 1989-05-11
EP0152270B1 (en) 1992-09-16
US4748018A (en) 1988-05-31
JPH08231426A (ja) 1996-09-10
DE3504221A1 (de) 1985-12-19
DK166905B1 (da) 1993-08-02
GR850323B (enExample) 1985-06-06
EP0395120B1 (en) 1996-03-06
JP2690476B2 (ja) 1997-12-10
EP0395120A2 (en) 1990-10-31
EP0152270A3 (en) 1988-01-27
DK227190D0 (da) 1990-09-20
ATE135016T1 (de) 1996-03-15
JPH08231424A (ja) 1996-09-10
JPH08231425A (ja) 1996-09-10
DK53485D0 (da) 1985-02-06
JPH04352729A (ja) 1992-12-07
JP2723870B2 (ja) 1998-03-09
IL74155A0 (en) 1985-04-30
CA1276884C (en) 1990-11-27
IE64365B1 (en) 1995-07-26
EP0395120A3 (en) 1990-12-19
AU3829685A (en) 1985-08-15
DK53485A (da) 1985-08-08
EP0152270A2 (en) 1985-08-21
NZ211030A (en) 1989-11-28
JP2698779B2 (ja) 1998-01-19
JP2698778B2 (ja) 1998-01-19
DK227190A (da) 1990-09-20
JP2543633B2 (ja) 1996-10-16
IE850289L (en) 1985-08-07
HK1000183A1 (en) 1998-01-23

Similar Documents

Publication Publication Date Title
US4748018A (en) Method of passive immunization of mammals using avian antibody
HK1000183B (en) Method of passive immunization of mammals using bovid antibody and compositions for same
Tsubokura et al. Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni‐infected chickens
Carlander et al. Peroral immunotheraphy with yolk antibodies for the prevention and treatment of enteric infections
Van den Broeck et al. Induction of immune responses in pigs following oral administration of purified F4 fimbriae
Stokes et al. The immune response of mice to bacterial antigens given by mouth
US4171354A (en) Vaccine for animal respiratory diseases
Boesman-Finkelstein et al. Bovine lactogenic immunity against cholera toxin-related enterotoxins and Vibrio cholerae outer membranes
US5130128A (en) Use of honey as vaccine
KR100267746B1 (ko) 돼지 대장균 설사증 예방 및 치료용 난황항체를 이용한 경구용 면역제제
US20070264264A1 (en) Method and composition for conferring immunity in mammals
KR19980081625A (ko) 장관 출혈성 대장균에 의한 감염증의 예방제 및 치료제
Landon et al. Antibody production in the hen
US6939954B2 (en) Isolated bovine lgG heavy chain protein and its use as an antimicrobial
US20080124321A1 (en) ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL
WO1996010420A1 (en) Composition and treatment for hyperimmunization with non heat-killed bacteria
IE75217B1 (en) Method of passive immunization of mammals using bovid antibody and compositions for same
Mori et al. Venom and antivenom of the redback spider (Latrodectus hasseltii) in Japan. Part II. Experimental production of equine antivenom against the redback spider
Lee Anti-bacterial activities of chicken egg yolk antibody (IgY) against enteric pathogens
Akita Chicken egg yolk immunoglobulin Y and fragments: purification, allergenicity and their neutralization of Escherichia coli heat labile toxin
Tiwary et al. Suppression of IgA synthesis in chickens

Legal Events

Date Code Title Description
MKEX Expiry